ResMed Inc.RMDNYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR+92.0%
5Y CAGR+38.8%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+92.0%/yr
vs -63.1%/yr prior
5Y CAGR
+38.8%/yr
Recent acceleration
Acceleration
+155.1pp
Accelerating
Percentile
P85
Within normal range
vs 5Y Ago
5.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 11.43% |
| Q3 2025 | -1.76% |
| Q2 2025 | 6.63% |
| Q1 2025 | 2.16% |
| Q4 2024 | 7.73% |
| Q3 2024 | 1.60% |
| Q2 2024 | 1.77% |
| Q1 2024 | 36.17% |
| Q4 2023 | -4.81% |
| Q3 2023 | 4.99% |
| Q2 2023 | -8.45% |
| Q1 2023 | 7.31% |
| Q4 2022 | 1.62% |
| Q3 2022 | 7.97% |
| Q2 2022 | 9.02% |
| Q1 2022 | -5.81% |
| Q4 2021 | -5.04% |
| Q3 2021 | 8.39% |
| Q2 2021 | 8.15% |
| Q1 2021 | 0.77% |
| Q4 2020 | 2.22% |
| Q3 2020 | -2.84% |
| Q2 2020 | 2.64% |
| Q1 2020 | 9.95% |
| Q4 2019 | 15.61% |
| Q3 2019 | 41.32% |
| Q2 2019 | -22.87% |
| Q1 2019 | -0.06% |
| Q4 2018 | 8.98% |
| Q3 2018 | -1.87% |
| Q2 2018 | 7.71% |
| Q1 2018 | -6.60% |
| Q4 2017 | 29.73% |
| Q3 2017 | -11.62% |
| Q2 2017 | 18.59% |
| Q1 2017 | 10.84% |
| Q4 2016 | 2.92% |
| Q3 2016 | -20.64% |
| Q2 2016 | 13.73% |
| Q1 2016 | -3.39% |